The macrophage foam cell as a target for therapeutic intervention.
Li
Andrew C
AC
Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California, USA.
Glass
Christopher K
CK
D000818:Animals; D001161:Arteriosclerosis / Q000378:metabolism / Q000473:pathology* / Q000517:prevention & control / Q000628:therapy; D001692:Biological Transport; D002784:Cholesterol / Q000378:metabolism; D005487:Foam Cells / Q000187:drug effects*; D006801:Humans; D008071:Lipoprotein Lipase / Q000378:metabolism; D008214:Lymphocytes / Q000166:cytology; D008565:Membrane Proteins; D010084:Oxidation-Reduction; D011971:Receptors, Immunologic / Q000378:metabolism; D011973:Receptors, LDL / Q000378:metabolism; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; D051122:Scavenger Receptors, Class B; D014280:Triglycerides / Q000378:metabolism
D008565:Membrane Proteins; D011971:Receptors, Immunologic; D011973:Receptors, LDL; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; C454739:Scarb1 protein, mouse; D051122:Scavenger Receptors, Class B; D014280:Triglycerides; D002784:Cholesterol; D008071:Lipoprotein Lipase